Concourse Financial Group Securities’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,465
| Closed | -$126K | – | 2411 |
|
|
2024
Q2 | $126K | Hold |
3,465
| – | – | 0.01% | 855 |
|
|
2024
Q1 | $132K | Buy |
3,465
+200
| +6% | +$7.43K | 0.01% | 822 |
|
|
2023
Q4 | $119K | Sell |
3,265
-100
| -3% | -$2.99K | 0.01% | 847 |
|
|
2023
Q3 | $101K | Sell |
3,365
-75
| -2% | -$2.52K | 0.01% | 851 |
|
|
2023
Q2 | $124K | Sell |
3,440
-375
| -10% | -$13.4K | 0.01% | 803 |
|
|
2023
Q1 | $127K | Sell |
3,815
-829
| -18% | -$28.9K | 0.01% | 803 |
|
|
2022
Q4 | $156K | Sell |
4,644
-519
| -10% | -$17.5K | 0.01% | 685 |
|
|
2022
Q3 | $177K | Sell |
5,163
-40
| -0.8% | -$1.45K | 0.02% | 567 |
|
|
2022
Q2 | $168K | Buy |
5,203
+39
| +0.8% | +$1.3K | 0.01% | 638 |
|
|
2022
Q1 | $204K | Buy |
5,164
+1,188
| +30% | +$46.9K | 0.02% | 633 |
|
|
2021
Q4 | $190K | Buy |
3,976
+470
| +13% | +$24.2K | 0.01% | 746 |
|
|
2021
Q3 | $192K | Buy |
3,506
+430
| +14% | +$24.3K | 0.01% | 729 |
|
|
2021
Q2 | $187K | Buy |
3,076
+1,399
| +83% | +$80.1K | 0.01% | 743 |
|
|
2021
Q1 | $97K | Buy |
1,677
+166
| +11% | +$10.4K | 0.01% | 947 |
|
|
2020
Q4 | $89K | Buy |
1,511
+203
| +16% | +$11K | 0.01% | 947 |
|
|
2020
Q3 | $62K | Buy |
1,308
+433
| +49% | +$19.7K | 0.01% | 978 |
|
|
2020
Q2 | $39K | Buy |
+875
| New | +$34.9K | ﹤0.01% | 1070 |
|
Concourse Financial Group Securities's BTEC Position: Q3 2024 in Review
Concourse Financial Group Securities sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q3 2024, closing a stake of 3,465 shares — an estimated $126K sold.
Concourse Financial Group Securities first reported a position in BTEC in Q2 2020 and held it in 17 quarters. The position peaked at $204K in Q1 2022. 0 funds tracked by Wall St. Rank hold BTEC as of Q3 2024.
- Concourse Financial Group Securities reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q3 2024 after selling out during the quarter.
- Concourse Financial Group Securities sold 3,465 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q3 2024, an estimated $126K.
- Concourse Financial Group Securities first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q2 2020 and held it in 17 quarters.
- Concourse Financial Group Securities's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $204K in Q1 2022.
- 0 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q3 2024.
Based on Concourse Financial Group Securities's 13F filing for Q3 2024, filed 10 Oct 2024.